Co-Diagnostics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Co-Diagnostics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q2 2024.
  • Co-Diagnostics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $101K, a 87.9% decline year-over-year.
  • Co-Diagnostics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $2.89M, a 58.1% decline year-over-year.
  • Co-Diagnostics, Inc. annual Nonoperating Income (Expense) for 2023 was $4.6M, a 43.5% decline from 2022.
  • Co-Diagnostics, Inc. annual Nonoperating Income (Expense) for 2022 was $8.13M.
  • Co-Diagnostics, Inc. annual Nonoperating Income (Expense) for 2021 was -$429K, a 149% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.89M $101K -$736K -87.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $3.63M $970K -$965K -49.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.6M $983K -$94.2K -8.75% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $4.69M $840K -$2.22M -72.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $6.91M $837K +$118K +16.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $6.79M $1.94M -$1.34M -40.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $8.13M $1.08M +$1.14M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $6.99M $3.06M +$3.11M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.88M $719K +$580K +417% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $3.3M $3.28M +$3.73M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$429K -$64.4K +$152K +70.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 -$581K -$53.6K -$832K -107% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $251K $139K -$158K -53.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $408K -$450K -$467K -2787% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $875K -$217K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $779K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $297K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $16.8K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.